DBTX Insider Trading Activity and SEC Form 4 Filings
DBTX insider trading summary
No open-market insider purchases or sales of Decibel Therapeutics, Inc. (DBTX) have been reported on SEC Form 4 in the past 12 months.
Latest DBTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 3, 2022 | Anna Trask | See Remarks | Sell | $5 (1 @ $5.04) |
| Jan 3, 2022 | Anna Trask | See Remarks | Sell | $2K (377 @ $5.03) |
| Dec 2, 2021 | Anna Trask | See Remarks | Sell | $2K (378 @ $6.34) |
| Dec 2, 2021 | Anna Trask | See Remarks | Sell | $31K (4,913 @ $6.37) |
| Nov 3, 2021 | Anna Trask | See Remarks | Sell | $3K (378 @ $8.34) |
| Nov 2, 2021 | Anna Trask | See Remarks | Sell | $41K (4,913 @ $8.31) |
| Oct 14, 2021 | Anna Trask | See Remarks | Sell | $40K (5,364 @ $7.55) |
| Sep 15, 2021 | Laurence Reid | President and Chief Executive | Buy | $76K (10,000 @ $7.64) |
| Feb 17, 2021 | Orbimed Capital LLC | Director | Buy | $20.0M (1,111,100 @ $18.00) |
| Feb 17, 2021 | OrbiMed Genesis GP LLC | Director | Buy | $20.0M (1,111,100 @ $18.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.